Nalbuphine recalls
The FDA has published 3 recalls involving Nalbuphine since 2012. The latest was reported on 5 Nov 2014. Most were for sterility. Martin Avenue Pharmacy has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 5 Nov 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why nalbuphine is recalled
Companies
By year
All nalbuphine recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nalbuphine 10 mg/mL injection solution recalled | Martin Avenue Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Nalbuphine HCL 20 MG/ML Injectable, all presentations recalled | Beacon Hill Medical Pharmacy, P.C | Sterility | Nationwide |
| Drug | CLASS II | Nalbuphine HCl Injection, 20 mg/mL Multiple-dose Fliptop Vial recalledNalbuphine Hydrochloride | Hospira | Sterility | Nationwide |
Should you stop taking Nalbuphine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.